James A. Sikorski

Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ.

Quintiles Transnational Corp. provides biopharmaceutical development and commercial outsourcing services. It offers product development and integrated healthcare services, including commercial and observational solutions. The company was founded by Dennis B. Gillings and Gary Koch in September 1990 and is headquartered in Durham, NC.

AAIPharma, Inc. provides product development services to the pharmaceutical, biotechnology and medical device industries. Its services include drug delivery technologies, contract manufacturing, clinical packaging and distribution and bioanalytical services. The company was founded in 1979 and is headquartered in Wilmington, NC.

HLM Management Co. LLC (HLM Venture Partners) is a venture capital firm founded in 1983 by James J.Mahoney, Judy Lawrie and Haberkorn A.R. The firm is headquartered in Waltham, Massachusetts.

Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA.

Inhibitex, Inc. operates as an clinical-stage biopharmaceutical company. The firm develops differentiated anti-infective products to prevent or treat serious infections. Its research and development efforts are currently focused on oral, small molecule compounds to treat viral infections, and in particular, chronic infections caused by HCV and herpes zoster. The company was founded by Joseph M. Patti in May 1994 and is headquartered in Alpharetta, GA.

Metabolic Testing Services Corp. provides medical diagnostics services. Its product MET-test represents the culmination in the understanding of cardiopulmonary diseases and information technology. The company was founded by William S. Woulfin, Sundeep Chaudhry and Rajesh D. Patel in 2003 and is headquartered in Atlanta, GA.

Genoptix, Inc. provides specialized oncology diagnostics services. It offers a range of customizable clinical trial, custom assay development and companion diagnostics development services. The company was founded in 1999 by Tina S. Nova and is headquartered in Carlsbad, CA.

Aventura HQ, Inc. provides awareness computing for the healthcare industry. It offers desktop architecture solution for virtual desktops catering and improves the workflow of doctors and nurses by providing the information they need, when and where they need it. The company was founded by Joseph Jaudon and Jon Cooper in 2007 and is headquartered in Ellijay, GA.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

The Access Partnership Ltd. publishes safety books for children. The company was founded in 1999 and is headquartered in London, the United Kingdom.

Echelon Ventures (Echelon Ventures) is a venture capital firm founded in 2000 by Woody S Woodworth and Scott C McCabe. The firm is headquartered in Waltham, Massachusetts.

Axela, Inc. develops biosensor technology. It offers next generation, commercial stage, multiplex tools that provide enhanced analysis of proteins, DNA and RNA. The firm’s products include Ziplex System, autograph, metabolic, colon and breast cancer, inflammation Xpress chips, diffractive optics technology and sensors, dotLab mX System and dot-Avidin, Ready and Covalent products. The company was founded by M. Cynthia Goh, Richard Loo, B. Jane Goh and Richard McAloney in 2001 and is headquartered in Toronto, Canada.

The American College of Surgeons Oncology Group (ACOSOG) was established to evaluate the surgical management of patients with malignant solid tumors. ACOSOG is one of 10 cooperative groups funded by the National Cancer Institute (NCI) to develop and coordinate multi-institutional clinical trials. ACOSOG is the only cooperative group with studies focusing primarily on surgical objectives. ACOSOG currently has treatment protocols available in three major disease areas: . Breast Cancer . Gastrointestinal Cancer . Thoracic Cancer ACOSOG is composed of the Operations and Membership Center located at the Duke Clinical Research Institute on the Duke University Medical Center campus and the Statistics and Data Center located at the Mayo Clinic Cancer Center. ACOSOG's membership is comprised of investigators and research associates representing oncology treatment modalities and research-related concerns, including surgery, medical oncology, radiation oncology, diagnostic imaging, pathology, ethics, CRA/nursing and patient advocacy.

The American Association of Neurological Surgeons is an organization that provides resources and tools for neurosurgeons and trainees in the field. The organization is based in Rolling Meadows, IL. The company's website offers information on membership benefits, education and training opportunities, publications, patient resources, advocacy efforts, and career opportunities.

Alliance Technology Management Corp. (Alliance Technology Ventures) is an Independent Venture Capital firm founded in 1993 by Mike A. Henos. The firm is headquartered in US, Sarasota.

Salutria Pharmaceuticals, Inc. operates drug stores.

Global Center For Medical Innovation, Inc. provides medical devices. It provides medical device commercialization, innovation, prototyping, machine shop, cGMP manufacturing, preclinical testing, clinical trial, inovator education, regulatory assurance, quality assurance, 3D Printing-ProJet 6000, rapid prototyping, cleanroom. The company is headquartered in Atlanta, GA.

Accolade Pharma LLC is a pharmaceutical company that specializes in developing topical formulations and devices for the active ingredient of Accolate® (zafirlukast) to treat allergic inflammation. The private company is based in Wilmington, DE. Leukotriene antagonists modify allergic responses by blocking leukotrienes, which prevents or decreases symptoms of acute inflammation such as wheezing, sneezing, itching, redness, and swelling. The company was founded in 2012 by G. John Mohr, who has been the CEO since 2012.

The Anesthesia Patient Safety Foundation focuses on perioperative patient safety priorities and ongoing activities. The private company is based in Indianapolis, IN. The company has a list of top 10 priorities and corresponding activities. The foundation also has a grant application process with a review process. The company formed the Perioperative Multi-Center Handoff Collaborative to improve patient handoffs. The foundation is launching a crowdfunding initiative to support their vision of no mishaps. The company also has a program to fund studies that improve patient safety and prevent mortality and morbidity. The Emergency Manuals Implementation Collaborative fosters adoption and effective use of emergency manuals.

Covanos, Inc. is an American medical technology company that has developed a technology platform combining advanced mathematical methods and computational fluid dynamics with clinical imaging to determine the functional significance of arterial blockages. The private company is based in Atlanta and was founded by Habib Samady. The company's first product, C-Heart, is a non-invasive, out-patient based, point-of-care, PC-based workstation solution that determines whether a patient with chest pain requires re-vascularization of a coronary artery blockage. Russell M. Medford has been the CEO of the company since 2014.